Combination of Two Photosensitisers in Anticancer, Antimicrobial and Upconversion Photodynamic Therapy
Open Access
- 19 April 2023
- journal article
- review article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (4) , 613
Abstract
Photodynamic therapy (PDT) is a special form of phototherapy in which oxygen is needed, in addition to light and a drug called a photosensitiser (PS), to create cytotoxic species that can destroy cancer cells and various pathogens. PDT is often used in combination with other antitumor and antimicrobial therapies to sensitise cells to other agents, minimise the risk of resistance and improve overall outcomes. Furthermore, the aim of combining two photosensitising agents in PDT is to overcome the shortcomings of the monotherapeutic approach and the limitations of individual agents, as well as to achieve synergistic or additive effects, which allows the administration of PSs in lower concentrations, consequently reducing dark toxicity and preventing skin photosensitivity. The most common strategies in anticancer PDT use two PSs to combine the targeting of different organelles and cell-death mechanisms and, in addition to cancer cells, simultaneously target tumour vasculature and induce immune responses. The use of PDT with upconversion nanoparticles is a promising approach to the treatment of deep tissues and the goal of using two PSs is to improve drug loading and singlet oxygen production. In antimicrobial PDT, two PSs are often combined to generate various reactive oxygen species through both Type I and Type II processes.Keywords
Funding Information
- University of Rijeka (uniri-prirod-18–173)
This publication has 206 references indexed in Scilit:
- Upconversion Nanoparticles for Photodynamic Therapy and Other Cancer TherapeuticsTheranostics, 2013
- Combinational Sensitization of Leishmania with Uroporphyrin and Aluminum Phthalocyanine Synergistically Enhances their Photodynamic Inactivation in vitro and in vivo†Photochemistry and Photobiology, 2012
- Upconversion nanoparticles: synthesis, surface modification and biological applicationsNanomedicine: Nanotechnology, Biology and Medicine, 2011
- Cell Death Pathways in Photodynamic Therapy of CancerCancers, 2011
- Photodynamic therapy of cancer: An updateCA: A Cancer Journal for Clinicians, 2011
- Streptococcus mutans, Caries and Simulation ModelsNutrients, 2010
- Targeting cancer cells by using an antireceptor antibody-photosensitizer fusion proteinProceedings of the National Academy of Sciences, 2009
- Milestones in the development of photodynamic therapy and fluorescence diagnosisPhotochemical & Photobiological Sciences, 2007
- Photodynamic therapy and anti-tumour immunityNature Reviews Cancer, 2006
- Photodynamic therapy: a new antimicrobial approach to infectious disease?Photochemical & Photobiological Sciences, 2004